Cereno Scientific AB (publ) Share Price NORDIC GROWTH MARKET
Equities
CRNO B
SE0008241558
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.521 SEK | -7.13% | +7.98% | -76.90% |
02/05 | Cereno Scientific AB Announces Nomination Committee Appointments Ahead of Annual General Meeting 2025 | CI |
16/04 | Cereno Scientific AB Approves Election of New Directors | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.06B 99.14M 8.25B |
---|---|---|---|---|---|
Net income 2024 * | -75M -7.02M -585M | Net income 2025 * | -42M -3.93M -327M | EV / Sales 2024 * | - |
Net Debt 2024 * | 3M 281K 23.39M | Net Debt 2025 * | 145M 13.6M 1.13B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-19.8
x | P/E ratio 2025 * |
-22.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.66% |
1 day | -7.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 01/15/01 | |
Eva Jagenheim
DFI | Director of Finance/CFO | 58 | 28/23/28 |
Fredrik Frick
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 71 | 12/12/12 | |
Director/Board Member | 71 | - | |
Director/Board Member | 47 | 12/12/12 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- CRNO B Stock
- CRNO B Stock